Reliability and Validity of the Newly Diagnosed Breast Cancer Stress Scale in the Greek Population.

Journal of molecular biochemistry Pub Date : 2020-01-01 Epub Date: 2020-12-30

Maria Charalampopoulou, Konstantinos Syrigos, Evaggelos Filopoulos, Vasileios Megalooikonomou, Dimitrios Vlachakis, George Chrousos, Christina Darviri

{"title":"Reliability and Validity of the Newly Diagnosed Breast Cancer Stress Scale in the Greek Population.","authors":"Maria Charalampopoulou, Konstantinos Syrigos, Evaggelos Filopoulos, Vasileios Megalooikonomou, Dimitrios Vlachakis, George Chrousos, Christina Darviri","doi":"","DOIUrl":null,"url":null,"abstract":"Objective: To examine the validity and the reliability of a novel measurement tool, the Newly Diagnosed Breast Cancer Stress Scale (NDBCSS) in the Greek population. The tool aimed to assess distress in patients recently diagnosed with breast cancer.Methods: We performed a principal component analysis (PCA) of the 17 items of the scale.Results: The PCA resulted in 4 factors: 1. Personal life, 2. Procedural issues, 3. Facing challenges and 4. Psychological load. All subscales showed satisfactory internal consistency and variance, relative to theoretical score ranges. Subscale scores and total score were significantly correlated with perceived stress and hospital anxiety and depression scale, implying good criterion validity. Associations with social, demographic and disease related information were also found.Conclusions: The NDBCSS resulted in acceptable reliability and good validity, and was considered as a valuable tool for health-care workers and oncologists to measure psychological distress in early stage of breast cancer.","PeriodicalId":73836,"journal":{"name":"Journal of molecular biochemistry","volume":"9 ","pages":"5-12"},"PeriodicalIF":0.0000,"publicationDate":"2020-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7861504/pdf/nihms-1661772.pdf","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Journal of molecular biochemistry","FirstCategoryId":"1085","ListUrlMain":"","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2020/12/30 0:00:00","PubModel":"Epub","JCR":"","JCRName":"","Score":null,"Total":0}

引用次数: 0

Abstract

Objective: To examine the validity and the reliability of a novel measurement tool, the Newly Diagnosed Breast Cancer Stress Scale (NDBCSS) in the Greek population. The tool aimed to assess distress in patients recently diagnosed with breast cancer.

Methods: We performed a principal component analysis (PCA) of the 17 items of the scale.

Results: The PCA resulted in 4 factors: 1. Personal life, 2. Procedural issues, 3. Facing challenges and 4. Psychological load. All subscales showed satisfactory internal consistency and variance, relative to theoretical score ranges. Subscale scores and total score were significantly correlated with perceived stress and hospital anxiety and depression scale, implying good criterion validity. Associations with social, demographic and disease related information were also found.

Conclusions: The NDBCSS resulted in acceptable reliability and good validity, and was considered as a valuable tool for health-care workers and oncologists to measure psychological distress in early stage of breast cancer.

本刊更多论文

希腊人群中新诊断乳腺癌应激量表的信度和效度。

目的:检验一种新型测量工具——新诊断乳腺癌应激量表(NDBCSS)在希腊人群中的有效性和可靠性。该工具旨在评估最近被诊断患有乳腺癌的患者的痛苦程度。方法:对量表的17个条目进行主成分分析(PCA)。结果:PCA导致4个因素:1。2.个人生活;程序问题;4.面对挑战;心理负荷。相对于理论评分范围，所有分量表均表现出令人满意的内部一致性和方差。子量表得分和总分与感知压力和医院焦虑抑郁量表显著相关，表明量表效度良好。还发现了与社会、人口和疾病相关信息的关联。结论:NDBCSS具有可接受的信度和良好的效度，可作为卫生保健工作者和肿瘤学家测量乳腺癌早期心理困扰的一种有价值的工具。

本文章由计算机程序翻译，如有差异，请以英文原文为准。

求助全文

约1分钟内获得全文求助全文

来源期刊

Journal of molecular biochemistry

自引率

0.00%

发文量

审稿时长

6 weeks